AblaCor Medical Corporation

    AblaCor is an early-stage medical device company headquartered near Boston. Its initial product is the CircumBlator™ AF Catheter Ablation System to advance the standard pulmonary vein isolation (PVI) procedure for patients with atrial fibrillation (AFib), the most common irregular heart rhythm and a potentially deadly disorder. CircumBlator is designed to overcome the limitations of currently available ablation catheters for treating AFib by producing durable, continuous, transmural lesions. AblaCor has a strong portfolio of patents issued and pending.